Home/Filings/4/0000950170-24-068981
4//SEC Filing

Olugemo Olukemi 4

Accession 0000950170-24-068981

CIK 0001703647other

Filed

Jun 3, 8:00 PM ET

Accepted

Jun 4, 7:12 PM ET

Size

5.5 KB

Accession

0000950170-24-068981

Insider Transaction Report

Form 4
Period: 2024-06-03
Olugemo Olukemi
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-06-03+65,00065,000 total
    Exercise: $50.48Exp: 2034-06-02Common Stock (65,000 underlying)
Footnotes (1)
  • [F1]The shares subject to the option vest as to 25% of the shares on May 13, 2025, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.

Documents

1 file

Issuer

Korro Bio, Inc.

CIK 0001703647

Entity typeother

Related Parties

1
  • filerCIK 0002022212

Filing Metadata

Form type
4
Filed
Jun 3, 8:00 PM ET
Accepted
Jun 4, 7:12 PM ET
Size
5.5 KB